Perioperative Outcomes from a Phase II Study of Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Gastric Cancer and Limited Peritoneal Metastasis: ROBO-CHIP Trial.

Saved in:
Bibliographic Details
Title: Perioperative Outcomes from a Phase II Study of Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Gastric Cancer and Limited Peritoneal Metastasis: ROBO-CHIP Trial.
Authors: Buckarma E; Department of Surgery, Rochester, MN, USA. Buckarma.EeeLN@mayo.edu., Steadman J; Department of Surgery, Rochester, MN, USA., Harmsen W; Department of Clinical Trials and Biostatistics at Mayo Clinic, Rochester, MN, USA., Mandrekar J; Department of Clinical Trials and Biostatistics at Mayo Clinic, Rochester, MN, USA., Daniel S; Department of Surgery, Rochester, MN, USA., Grotz TE; Department of Surgery, Rochester, MN, USA.
Source: Annals of surgical oncology [Ann Surg Oncol] 2026 Jul; Vol. 33 (7), pp. 6185-6193. Date of Electronic Publication: 2026 Apr 10.
Publication Type: Journal Article; Clinical Trial, Phase II
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first